UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CERE
4251
PUT
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $1.18M | ﹤0.01% |
28,800
-27,600
| -49% | -$1.15M |
|
4252
F&G Annuities & Life
FG
$3.55B
| $1.18M | ﹤0.01% |
30,932
-18,961
| -38% | -$743K |
|
|
SEM
4253
DELISTED
Select Medical
SEM
| $1.18M | ﹤0.01% |
62,289
-106,652
| -63% | -$1.82M |
|
4254
AAR Corp
AIR
$5.74B
| $1.18M | ﹤0.01% |
16,174
-21,023
| -57% | -$1.43M |
|
|
VSXY
4255
CALL
Victoria's Secret
VSXY
$7.95B
| $1.18M | ﹤0.01% |
66,500
| – | – |
|
4256
Anixa Biosciences
ANIX
$111M
| $1.17M | ﹤0.01% |
530,540
-5,767
| -1% | -$16.4K |
|
4257
NB Bancorp
NBBK
$989M
| $1.17M | ﹤0.01% |
77,744
+50,246
| +183% | +$732K |
|
4258
Protolabs
PRLB
$2.14B
| $1.17M | ﹤0.01% |
37,937
+2,562
| +7% | +$81.2K |
|
4259
Sphere Entertainment
SPHR
$5.84B
| $1.17M | ﹤0.01% |
33,418
-69,858
| -68% | -$2.72M |
|
4260
Alpha and Omega Semiconductor
AOSL
$1.03B
| $1.17M | ﹤0.01% |
31,326
+13,740
| +78% | +$363K |
|
4261
CALL
AstraZeneca
AZN
$251B
| $1.17M | ﹤0.01% |
7,500
+800
| +12% | +$120K |
|
4262
HNI Corp
HNI
$3.54B
| $1.17M | ﹤0.01% |
25,984
-36,390
| -58% | -$1.61M |
|
4263
CALL
Becton Dickinson
BDX
$48.9B
| $1.17M | ﹤0.01% |
5,000
| – | – |
|
4264
Invesco Bloomberg MVP Multi-factor ETF
BMVP
$106M
| $1.17M | ﹤0.01% |
26,528
-1,264
| -5% | -$55.5K |
|
4265
Global X Autonomous & Electric Vehicles ETF
DRIV
$392M
| $1.17M | ﹤0.01% |
49,673
+44,621
| +883% | +$1.07M |
|
4266
Nuvation Bio
NUVB
$2.32B
| $1.17M | ﹤0.01% |
399,583
-24,219
| -6% | -$73.9K |
|
4267
CALL
AB InBev
BUD
$164B
| $1.16M | ﹤0.01% |
+20,000
| New | +$1.23M |
|
|
4268
PUT
AB InBev
BUD
$164B
| $1.16M | ﹤0.01% |
+20,000
| New | +$1.23M |
|
4269
ACV Auctions
ACVA
$1.27B
| $1.16M | ﹤0.01% |
63,664
-81,792
| -56% | -$1.47M |
|
4270
AZZ Inc
AZZ
$4.58B
| $1.16M | ﹤0.01% |
15,039
-11,952
| -44% | -$934K |
|
4271
Graham Holdings Company
GHC
$4.99B
| $1.16M | ﹤0.01% |
1,660
-2,911
| -64% | -$2.13M |
|
4272
CryoPort
CYRX
$751M
| $1.16M | ﹤0.01% |
167,854
+29,583
| +21% | +$398K |
|
|
IGA
4273
Voya Global Advantage and Premium Opportunity Fund
IGA
$158M
| $1.16M | ﹤0.01% |
130,960
-76,614
| -37% | -$674K |
|
4274
Apple Hospitality REIT
APLE
$3.71B
| $1.16M | ﹤0.01% |
79,605
-134,109
| -63% | -$2M |
|
|
IDE
4275
Voya Infrastructure, Industrials and Materials Fund
IDE
$199M
| $1.16M | ﹤0.01% |
113,134
+7,982
| +8% | +$82K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.